Feds, BC invest nearly $73 million into Aspect Biosystems to establish biomanufacturing facility
The clinical facility aims to be the first dedicated to producing bioprinted tissue therapeutics in Canada.
The clinical facility aims to be the first dedicated to producing bioprinted tissue therapeutics in Canada.
Neuroscientist and former Google Pixel PM team up to tackle workplace stress with Roga.
LifeLabs will retain its brand, Canadian headquarters, and management after the acquisition is closed.
Healwell CEO touts access to xAI’s closed developer program as big potential benefit.
Private contributions bring the collective project values up to $32 million.
FedDev invested nearly $20 million across nine Ottawa-based companies.
VoxCell’s 3D bioprinted imitation of natural soft tissue helps pharmaceutical companies test new drugs faster.
Plus: Telehealth execs charged with fraud.
The deals, if successful, will have a combined value of over $36 million.
Each startup is receiving between $150,000 to $500,000 based on company stage, needs, and evaluation processes.
Heylist, Vosyn, Pok Pok, and Ability Biologics have all raised fresh capital.
Plus: Feds table bill with new healthtech data security rules.
The financing follows Kardium’s $158-million CAD round in 2021.
Plus: The new Alberta program looking to connect the healthtech ecosystem.
GreenSky-backed University of Toronto spinout has set its initial sights on dentistry.